Silence Therapeutics appoints chairman
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Silence Therapeutics plc appointed Annalisa Jenkins the nonexecutive chairman of the company's board of directors.
Stephen Parker, the company's former nonexecutive chairman, will transition to a nonexecutive director role.
Jenkins is the CEO of Dimension Therapeutics Inc.
